- idUS
- Listar por autor
Listar por autor "Rodríguez-Hernández, María A."
Mostrando ítems 1-2 de 2
-
Artículo
Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells
Rodríguez-Hernández, María A.; Chapresto-Garzón, Raquel; Cadenas, Miryam; Navarro-Villarán, Elena; Negrete, María; Gómez Bravo, Miguel Ángel; Padillo Ruiz, Francisco Javier; Muntané Relat, Jordi (Springer Nature, 2020)Sorafenib and Regorafenib are the recommended first- and second-line therapies in patients with advanced hepatocellular ...
-
Artículo
Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cáncer
González, Raúl; Rodríguez-Hernández, María A.; Negrete, María; Ranguelova, Kalina; Rossin, Aurelie; Choya-Foces, Carmen; Cruz-Ojeda, Patricia de la; Muntané Relat, Jordi (Elsevier, 2020)Hepatocellular carcinoma (HCC) represents 80% of the primary hepatic neoplasms. It is the sixth most frequent neoplasm, ...